Deutsche Bank sets Harmony Biosciences stock Buy rating, $55 target
Deutsche Bank (ETR:DBKGn) initiated coverage on Harmony Biosciences Holdings Inc. (NASDAQ: NASDAQ:HRMY), assigning a Buy rating and setting a price target of $55. The firm's analysts highlighted ...